罗氏应对关键药物动力减弱与第三季度汇率波动，但仍保持增长势头——激烈制药报道
Roche contends with loss of momentum for key medicines, currency fluctuations in Q3 but keeps growth on track Fierce Pharma
Roche contends with loss of momentum for key medicines, currency fluctuations in Q3 but keeps growth on track Fierce Pharma